- Home
- CTMX vs GRWG Comparison
CTMX vs GRWG Comparison
Compare CTMX & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- GRWG
- Stock Information
- Founded
- CTMX 2008
- GRWG 2008
- Country
- CTMX United States
- GRWG United States
- Employees
- CTMX N/A
- GRWG N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- GRWG RETAIL: Building Materials
- Sector
- CTMX Health Care
- GRWG Consumer Discretionary
- Exchange
- CTMX Nasdaq
- GRWG Nasdaq
- Market Cap
- CTMX 444.3M
- GRWG 60.6M
- IPO Year
- CTMX 2015
- GRWG N/A
- Fundamental
- Price
- CTMX $2.50
- GRWG $1.01
- Analyst Decision
- CTMX Strong Buy
- GRWG Buy
- Analyst Count
- CTMX 2
- GRWG 4
- Target Price
- CTMX $5.00
- GRWG $2.38
- AVG Volume (30 Days)
- CTMX 2.6M
- GRWG 948.2K
- Earning Date
- CTMX 08-07-2025
- GRWG 08-07-2025
- Dividend Yield
- CTMX N/A
- GRWG N/A
- EPS Growth
- CTMX 128.27
- GRWG N/A
- EPS
- CTMX 0.49
- GRWG N/A
- Revenue
- CTMX $147,557,000.00
- GRWG $176,681,000.00
- Revenue This Year
- CTMX N/A
- GRWG N/A
- Revenue Next Year
- CTMX N/A
- GRWG N/A
- P/E Ratio
- CTMX $5.15
- GRWG N/A
- Revenue Growth
- CTMX 23.81
- GRWG N/A
- 52 Week Low
- CTMX $0.40
- GRWG $0.82
- 52 Week High
- CTMX $3.10
- GRWG $2.70
- Technical
- Relative Strength Index (RSI)
- CTMX 57.13
- GRWG 44.82
- Support Level
- CTMX $2.15
- GRWG $0.87
- Resistance Level
- CTMX $2.44
- GRWG $1.05
- Average True Range (ATR)
- CTMX 0.22
- GRWG 0.07
- MACD
- CTMX -0.03
- GRWG -0.01
- Stochastic Oscillator
- CTMX 41.67
- GRWG 41.18
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.